These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36905149)

  • 1. Natural History of Clostridioides difficile Colonization and Infection Following New Acquisition of Carriage in Healthcare Settings: A Prospective Cohort Study.
    Curry SR; Hecker MT; O'Hagan J; Kutty PK; Alhmidi H; Ng-Wong YK; Cadnum JL; Jencson AL; Gonzalez-Orta M; Saldana C; Wilson BM; Donskey CJ
    Clin Infect Dis; 2023 Jul; 77(1):77-83. PubMed ID: 36905149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains.
    Stoesser N; Eyre DW; Quan TP; Godwin H; Pill G; Mbuvi E; Vaughan A; Griffiths D; Martin J; Fawley W; Dingle KE; Oakley S; Wanelik K; Finney JM; Kachrimanidou M; Moore CE; Gorbach S; Riley TV; Crook DW; Peto TEA; Wilcox MH; Walker AS;
    PLoS One; 2017; 12(8):e0182307. PubMed ID: 28813461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors for asymptomatic Clostridium difficile carriage.
    Alasmari F; Seiler SM; Hink T; Burnham CA; Dubberke ER
    Clin Infect Dis; 2014 Jul; 59(2):216-22. PubMed ID: 24755858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
    Curry SR; Muto CA; Schlackman JL; Pasculle AW; Shutt KA; Marsh JW; Harrison LH
    Clin Infect Dis; 2013 Oct; 57(8):1094-102. PubMed ID: 23881150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals.
    Le Monnier A; Candela T; Mizrahi A; Bille E; Bourgeois-Nicolaos N; Cattoir V; Farfour E; Grall I; Lecointe D; Limelette A; Marcade G; Poilane I; Poupy P; Kansau I; Zahar JR; Pilmis B;
    J Hosp Infect; 2022 Nov; 129():65-74. PubMed ID: 35640734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated with Clostridioides (Clostridium) Difficile Infection and Colonization: Ongoing Prospective Cohort Study in a French University Hospital.
    Khanafer N; Vanhems P; Bennia S; Martin-Gaujard G; Juillard L; Rimmelé T; Argaud L; Martin O; Huriaux L; Marcotte G; Hernu R; Floccard B; Cassier P; Group S
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299978
    [No Abstract]   [Full Text] [Related]  

  • 7. Clostridioides difficile colonization and infection in a cohort of Australian adults with cystic fibrosis.
    Tai AS; Putsathit P; Eng L; Imwattana K; Collins DA; Mulrennan S; Riley TV
    J Hosp Infect; 2021 Jul; 113():44-51. PubMed ID: 33775742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition of Clostridium difficile Colonization and Infection After Transfer From a Veterans Affairs Hospital to an Affiliated Long-Term Care Facility.
    Ponnada S; Guerrero DM; Jury LA; Nerandzic MM; Cadnum JL; Alam MJ; Donskey CJ
    Infect Control Hosp Epidemiol; 2017 Sep; 38(9):1070-1076. PubMed ID: 28693636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease.
    Meltzer E; Smollan G; Huppert A; Fluss R; Tal I; Gilboa M; Zilberman-Daniels T; Keller N; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2019 Sep; 25(9):1127-1132. PubMed ID: 30771530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom.
    Miyajima F; Roberts P; Swale A; Price V; Jones M; Horan M; Beeching N; Brazier J; Parry C; Pendleton N; Pirmohamed M
    PLoS One; 2011; 6(8):e22804. PubMed ID: 21886769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxigenic
    Keegan J; Buchan BW; Ledeboer NA; Zhou Z; Hong JC; Graham MB; Munoz-Price LS
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):287-291. PubMed ID: 32933595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
    Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization and genotyping of isolates from cancer patients with
    de-la-Rosa-Martinez D; Bobadilla Del Valle M; Esteban-Kenel V; Zinser Peniche P; Ponce De León Garduño A; Cornejo Juárez P; Sánchez Cruz MN; Camacho-Ortiz A; Vilar-Compte D
    J Med Microbiol; 2023 Aug; 72(8):. PubMed ID: 37624363
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening of
    Baron SW; Ostrowsky BE; Nori P; Drory DY; Levi MH; Szymczak WA; Rinke ML; Southern WN
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):149-153. PubMed ID: 31822302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia.
    Zainul NH; Ma ZF; Besari A; Siti Asma H; Rahman RA; Collins DA; Hamid N; Riley TV; Lee YY
    Epidemiol Infect; 2017 Oct; 145(14):3012-3019. PubMed ID: 28891459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors of toxigenic
    Jolivet S; Couturier J; Grohs P; Vilfaillot A; Zahar JR; Frange P; Casetta A; Moulin V; Lawrence C; Baune P; Bourgeois C; Bouffier A; Laussucq C; Sienzonit L; Picard S; Podglajen I; Kassis-Chikhani N; Barbut F
    Front Med (Lausanne); 2023; 10():1221363. PubMed ID: 37547619
    [No Abstract]   [Full Text] [Related]  

  • 17. Ribotype variability of Clostridioides difficile strains in patients with hospital-acquired C. difficile infections, community-acquired C. difficile infections, and colonization with toxigenic and non-toxigenic strains of C. difficile.
    Kim B; Seo MR; Kim J; Pai H
    Anaerobe; 2019 Dec; 60():102086. PubMed ID: 31404682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Determination of Relative Risks for Clostridioides difficile Infection From Asymptomatic Carriage in Intensive Care Unit Patients.
    Worley J; Delaney ML; Cummins CK; DuBois A; Klompas M; Bry L
    Clin Infect Dis; 2021 Oct; 73(7):e1727-e1736. PubMed ID: 32676661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.